
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, cond...
Radio and PodcastLive Radio & PodcastsOpening Radio and Podcast...

Radio and PodcastLive Radio & PodcastsFetching podcast shows and categories...
Radio and PodcastLive Radio & PodcastsFetching podcast episodes...

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the worl...

DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, cond...

This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs...

In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future...

Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other auth...

Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes t...

Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2...

A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a...

In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulat...

In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in...

DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clin...

“Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance b...

For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19...

“The pandemic had a substantial impact on community understanding of clinical trials. Having said that, the sort of ambient level of communi...

From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this...

While the African Medicines Agency (AMA) plans and plants its inaugural headquarters in Rwanda, the European Commission, the European Medici...

Clinical trials struggle to enroll eligible patients, while interested patients have difficulty finding pertinent clinical trials. Can techn...

Actions to increase patient diversity in clinical research initially addressed racial and ethnic demographics but are expanding to address g...

Digital technologies are rippling through clinical research and care, promising deeper links between healthcare research and delivery. In he...

DIA Global Forum ’s annual review of new drug approvals in China has shown growth in both the number and types of new drugs approved in Chin...

The World Health Organization has initiated a pilot coordinated scientific advice (CSA) procedure whereby product developers may obtain WHO...